questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Composants de génome
Gènes
Composants de gène
Régions non traduites
Régions 3' non traduites
Régions 3' non traduites : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Séquençage de l'ARN
Analyse bioinformatique
Électrophorèse
ARN messager
Mutations génétiques
Séquençage ciblé
Stabilité de l'ARN
Expression génique
Symptômes
5
Anomalies génétiques
Symptômes cliniques
Maladies génétiques
Symptômes
Réponse au traitement
Expression génique
Syndromes génétiques
Mutations
Prévention
5
Dépistage génétique
Prévention des maladies
Mode de vie sain
Tests génétiques
Antécédents familiaux
Risques génétiques
Programmes de prévention
Sensibilisation
Mode de vie
Expression génique
Traitements
5
Thérapie génique
Traitement médicamenteux
Thérapies ciblées
Expression génique
Modification génétique
Recherche médicale
Régulation génique
Traitements
Médicaments
Recherche pharmacologique
Complications
5
Complications médicales
Troubles génétiques
Cancers
Altérations génétiques
Troubles neurologiques
Mutations génétiques
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Facteurs environnementaux
Expression génique
Habitudes de vie
Tabagisme
Mutations
Régions codantes
Tests génétiques
Évaluation des risques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Régions 3' non traduites : Questions médicales les plus fréquentes",
"headline": "Régions 3' non traduites : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Régions 3' non traduites : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-30",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Régions 3' non traduites"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Régions non traduites",
"url": "https://questionsmedicales.fr/mesh/D020506",
"about": {
"@type": "MedicalCondition",
"name": "Régions non traduites",
"code": {
"@type": "MedicalCode",
"code": "D020506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.137.910"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Éléments riches en AU",
"alternateName": "AU Rich Elements",
"url": "https://questionsmedicales.fr/mesh/D063307",
"about": {
"@type": "MedicalCondition",
"name": "Éléments riches en AU",
"code": {
"@type": "MedicalCode",
"code": "D063307",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.137.910.880.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Régions 3' non traduites",
"alternateName": "3' Untranslated Regions",
"code": {
"@type": "MedicalCode",
"code": "D020413",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fan Jiang",
"url": "https://questionsmedicales.fr/author/Fan%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Dong-Zhi Li",
"url": "https://questionsmedicales.fr/author/Dong-Zhi%20Li",
"affiliation": {
"@type": "Organization",
"name": "Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Kevin Struhl",
"url": "https://questionsmedicales.fr/author/Kevin%20Struhl",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA."
}
},
{
"@type": "Person",
"name": "Raffaella Liccardo",
"url": "https://questionsmedicales.fr/author/Raffaella%20Liccardo",
"affiliation": {
"@type": "Organization",
"name": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy."
}
},
{
"@type": "Person",
"name": "Marina De Rosa",
"url": "https://questionsmedicales.fr/author/Marina%20De%20Rosa",
"affiliation": {
"@type": "Organization",
"name": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Awake Craniotomy Surgery in Pediatrics: A Systematic Review.",
"datePublished": "2023-08-17",
"url": "https://questionsmedicales.fr/article/37595837",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.wneu.2023.08.040"
}
},
{
"@type": "ScholarlyArticle",
"name": "Awake craniotomies in the pediatric population: a systematic review.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37410631",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/2023.4.PEDS22296"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Pterional Keyhole Craniotomy Approach: A Historical Perspective.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37429377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.wneu.2023.07.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mini-craniotomy for intra-axial brain tumors: a comparison with conventional craniotomy in 306 patients harboring non-dural based lesions.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/35585468",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10143-022-01811-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Unusual Case of Severe Trismus After Craniotomy.",
"datePublished": "2023-01-23",
"url": "https://questionsmedicales.fr/article/36727759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SCS.0000000000009186"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gènes",
"item": "https://questionsmedicales.fr/mesh/D005796"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composants de gène",
"item": "https://questionsmedicales.fr/mesh/D040461"
},
{
"@type": "ListItem",
"position": 8,
"name": "Régions non traduites",
"item": "https://questionsmedicales.fr/mesh/D020506"
},
{
"@type": "ListItem",
"position": 9,
"name": "Régions 3' non traduites",
"item": "https://questionsmedicales.fr/mesh/D020413"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Régions 3' non traduites - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Régions 3' non traduites",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Régions 3' non traduites",
"description": "Comment identifier les 3' UTR dans un gène ?\nQuels tests sont utilisés pour étudier les 3' UTR ?\nLes 3' UTR sont-ils visibles sur des électrophorèses ?\nPeut-on détecter des mutations dans les 3' UTR ?\nQuel rôle jouent les 3' UTR dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Craniotomy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Régions 3' non traduites",
"description": "Les 3' UTR sont-ils associés à des symptômes cliniques ?\nQuels symptômes peuvent résulter de mutations dans les 3' UTR ?\nLes 3' UTR affectent-ils la réponse aux traitements ?\nY a-t-il des symptômes spécifiques liés aux 3' UTR ?\nLes 3' UTR peuvent-ils être impliqués dans des syndromes ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Craniotomy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Régions 3' non traduites",
"description": "Peut-on prévenir les maladies liées aux 3' UTR ?\nQuels conseils pour réduire les risques liés aux 3' UTR ?\nLes antécédents familiaux influencent-ils la prévention ?\nY a-t-il des programmes de prévention pour les 3' UTR ?\nComment le mode de vie affecte-t-il les 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Craniotomy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Régions 3' non traduites",
"description": "Comment traiter les maladies liées aux 3' UTR ?\nLes thérapies ciblées affectent-elles les 3' UTR ?\nPeut-on modifier les 3' UTR pour traiter des maladies ?\nLes traitements peuvent-ils influencer les 3' UTR ?\nY a-t-il des médicaments ciblant les 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Craniotomy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Régions 3' non traduites",
"description": "Quelles complications peuvent survenir avec les 3' UTR ?\nLes 3' UTR sont-ils liés à des cancers ?\nComment les 3' UTR affectent-ils la santé ?\nLes complications des 3' UTR sont-elles héréditaires ?\nY a-t-il des complications neurologiques liées aux 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Craniotomy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Régions 3' non traduites",
"description": "Quels facteurs de risque sont associés aux 3' UTR ?\nL'environnement influence-t-il les 3' UTR ?\nLes habitudes de vie impactent-elles les 3' UTR ?\nLes mutations dans les 3' UTR sont-elles fréquentes ?\nY a-t-il des tests pour évaluer les risques liés aux 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Craniotomy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les 3' UTR dans un gène ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les 3' UTR peuvent être identifiés par séquençage d'ARN et analyses bioinformatiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les 3' UTR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le RT-PCR et les analyses de microarrays pour évaluer l'expression."
}
},
{
"@type": "Question",
"name": "Les 3' UTR sont-ils visibles sur des électrophorèses ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les 3' UTR ne sont pas visibles directement sur les gels d'électrophorèse."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des mutations dans les 3' UTR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations dans les 3' UTR peuvent être détectées par séquençage ciblé."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les 3' UTR dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer la stabilité de l'ARN et l'expression des gènes, affectant le diagnostic."
}
},
{
"@type": "Question",
"name": "Les 3' UTR sont-ils associés à des symptômes cliniques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, des anomalies dans les 3' UTR peuvent entraîner des symptômes par régulation génique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent résulter de mutations dans les 3' UTR ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations peuvent causer des maladies génétiques, entraînant divers symptômes."
}
},
{
"@type": "Question",
"name": "Les 3' UTR affectent-ils la réponse aux traitements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent influencer la réponse aux traitements en modifiant l'expression des gènes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques liés aux 3' UTR ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont généralement liés à des maladies spécifiques, pas aux 3' UTR eux-mêmes."
}
},
{
"@type": "Question",
"name": "Les 3' UTR peuvent-ils être impliqués dans des syndromes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des syndromes génétiques peuvent être associés à des mutations dans les 3' UTR."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux 3' UTR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage génétique peut aider à identifier les risques."
}
},
{
"@type": "Question",
"name": "Quels conseils pour réduire les risques liés aux 3' UTR ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain et se soumettre à des tests génétiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des programmes de prévention pour les 3' UTR ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de sensibilisation et de dépistage génétique existent pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie affecte-t-il les 3' UTR ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut influencer l'expression génique, y compris celle des 3' UTR."
}
},
{
"@type": "Question",
"name": "Comment traiter les maladies liées aux 3' UTR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la maladie sous-jacente, souvent par thérapies géniques ou médicamenteuses."
}
},
{
"@type": "Question",
"name": "Les thérapies ciblées affectent-elles les 3' UTR ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines thérapies ciblées peuvent moduler l'expression des gènes via les 3' UTR."
}
},
{
"@type": "Question",
"name": "Peut-on modifier les 3' UTR pour traiter des maladies ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches de modification des 3' UTR sont en recherche pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils influencer les 3' UTR ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent affecter la régulation des 3' UTR et l'expression génique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant les 3' UTR ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, peu de médicaments ciblent spécifiquement les 3' UTR, mais la recherche progresse."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les 3' UTR ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des maladies génétiques et des troubles de l'expression génique."
}
},
{
"@type": "Question",
"name": "Les 3' UTR sont-ils liés à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des altérations dans les 3' UTR peuvent être associées à certains types de cancers."
}
},
{
"@type": "Question",
"name": "Comment les 3' UTR affectent-ils la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils régulent l'expression des gènes, et des anomalies peuvent entraîner des problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les complications des 3' UTR sont-elles héréditaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être héréditaires, selon les mutations présentes dans les 3' UTR."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques liées aux 3' UTR ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations dans les 3' UTR peuvent être associées à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux 3' UTR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des environnements spécifiques."
}
},
{
"@type": "Question",
"name": "L'environnement influence-t-il les 3' UTR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent affecter l'expression des gènes régulés par les 3' UTR."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie impactent-elles les 3' UTR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes de vie, comme le tabagisme, peuvent influencer l'expression des 3' UTR."
}
},
{
"@type": "Question",
"name": "Les mutations dans les 3' UTR sont-elles fréquentes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations dans les 3' UTR sont moins fréquentes que dans les régions codantes, mais significatives."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests pour évaluer les risques liés aux 3' UTR ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent évaluer les risques associés aux mutations dans les 3' UTR."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
UT Southwestern Medical Center, Departments of Pharmacology and Biochemistry, Dallas, TX 75205, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA; School of Medicine and Genome Sciences, University of Washington, Seattle, WA 98195, USA. Electronic address: ahsieh@fredhutch.org.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Eye Center of Xiangya Hospital, Hunan Key Laboratory of Ophthalmology, Central South University, Changsha, China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.
Publications dans "Régions 3' non traduites" :
Awake craniotomy is a unique method to prevent motor deficits during the resection of lesions located in or close to functional areas. We sought to study the outcomes of pediatric craniotomy on publis...
The search for articles was performed through multiple search engines: PubMed, Google Scholar, Web of Science, and Wiley. The following search terms were used for screening the titles and abstracts: "...
The mean age group was 12.23 years. There was a slight difference between genders who underwent awake craniotomy in the pediatric age group, 52.7% male and 47.3% for female. Tumor resection was the mo...
This systematic review summarized that awake brain surgery can prevent significant motor and language deficits postoperatively in children after tumor resection as it is considered a feasible and safe...
Awake craniotomy (AC) is employed to maximize tumor resection while preserving neurological function in eloquent brain tissue. This technique is used frequently in adults but remains poorly establishe...
The authors followed PRISMA guidelines to extract studies that reported AC in children with intracranial pathologies. The Medline/PubMed, Ovid, and Embase databases were searched from database incepti...
Thirty eligible studies published from 1997 to 2020 were included that described a total of 130 children ranging in age from 7 to 17 years who had undergone AC. Of all patients reported, 59% were male...
The findings of this systematic review suggest the tolerability and safety of ACs in the pediatric population. Although pediatric intracranial pathologies pose etiologies that certainly may benefit fr...
The pterional craniotomy is a workhorse of cranial surgery that provides access to the anterior and middle fossae. However, newer "keyhole" approaches, such as the micropterional or pterional keyhole ...
The use of a mini-craniotomy approach involving linear skin incision and a bone flap of about 3 cm has been reported for several neurosurgical diseases, such as aneurysms or cranial base tumors. More ...
Myositis ossificans Traumatica (MOT) is a non-neoplastic, heterotrophic ossifying disease process in muscle and soft tissue rarely involving the craniofacial area. Treatment depends on the extent of o...
A man in his 40s with a history of coronary artery disease previously treated with a drug-eluting stent presented for elective craniotomy and resection of an asymptomatic but enlarging meningioma. Dur...
To assess the safety of foregoing invasive monitoring in a select group of patients undergoing awake craniotomy for supratentorial tumor resection....
Awake craniotomies were performed for tumor resection without invasive blood pressure monitoring when there was no preexisting cardiopulmonary indication as determined by the attending anesthesiologis...
At a single tertiary care hospital, 74 consecutive awake surgeries were performed with noninvasive blood pressure monitoring. Among patients, 39 (52.7%) were male, 42 (83.8%) had infiltrative primary ...
Intraoperative physiologic control and surgical site complication avoidance do not warrant routine invasive blood pressure monitoring during awake craniotomy for tumor resection....
Patients with brain tumours are increasingly treated by using the awake craniotomy technique. Some patients may experience anxiety when subjected to brain surgery while being fully conscious. However,...
In the current study, 62 adult patients completed questionnaires to identify the degree to which they experienced anxiety, depressive and post-traumatic stress complaints following awake craniotomy us...
In our sample, 21% of the patients reported pre-operative anxiety. Four weeks after surgery, 19% of the patients reported such complaints, and 24% of the patients reported anxiety complaints after 3 m...
The results of the present study do not indicate that undergoing awake craniotomy is associated with increased psychological complaints. Nevertheless, psychological complaints may well exist as a resu...
Traumatic acute subdural hematomas frequently warrant surgical evacuation by means of a craniotomy (bone flap replaced) or decompressive craniectomy (bone flap not replaced). Craniectomy may prevent i...
We conducted a trial in which patients undergoing surgery for traumatic acute subdural hematoma were randomly assigned to undergo craniotomy or decompressive craniectomy. An inclusion criterion was a ...
A total of 228 patients were assigned to the craniotomy group and 222 to the decompressive craniectomy group. The median diameter of the bone flap was 13 cm (interquartile range, 12 to 14) in both gro...
Among patients with traumatic acute subdural hematoma who underwent craniotomy or decompressive craniectomy, disability and quality-of-life outcomes were similar with the two approaches. Additional su...
Hypoglycemia is a known risk of intensive postoperative glucose control in neurosurgical patients. However, the impact of postoperative hypoglycemia after craniotomy remains unexplored. This study aim...
This study involved adult patients who underwent elective craniotomy at the West China Hospital, Sichuan University, between January 2011 and March 2021. We defined moderate hypoglycemia as blood gluc...
This study involved 15 040 patients undergoing an elective craniotomy. Overall, 504 (3.4%) patients experienced moderate hypoglycemia, whereas 125 (0.8%) patients experienced severe hypoglycemia. Mult...
Among patients undergoing an elective craniotomy, moderate hypoglycemia and severe hypoglycemia are associated with increased mortality, major morbidity, and prolonged hospital stays. In addition, the...